News

Article

What We’re Reading: Alabama IVF Ruling; UnitedHealth Antitrust Probe; Food as Medicine Initiative

Author(s):

Survey highlights widespread opposition to Alabama's law restricting in vitro fertilization (IVF) access; investigation focuses on potential anticompetitive practices; Medicare weighs options for implementing a new program to deliver healthy meals to seniors with chronic conditions.

Majority Disagrees With Alabama IVF Ruling

A recent survey revealed that most Americans oppose the Alabama Supreme Court's controversial in vitro fertilization (IVF) ruling, holding people legally responsible for destroying genetic material, according to The Hill. The findings underscore widespread disagreement with the law's implications for reproductive rights and access to assisted reproductive technologies. Critics argue that such restrictions undermine individual autonomy and perpetuate inequality in accessing reproductive health care.

DOJ Launches Antitrust Probe into UnitedHealth's Dominance

The Department of Justice (DOJ) has initiated an antitrust investigation into UnitedHealth, probing its extensive presence in health care, including insurance, drug benefits, and physician groups, according to The Wall Street Journal. Investigators are scrutinizing relationships between UnitedHealthcare and Optum, questioning potential anticompetitive effects on rivals and consumers. The inquiry reflects a broader effort by the Biden administration to curb monopolistic practices in the health care industry and ensure fair competition for consumers and providers alike.

Medicare Explores Food as Medicine Initiative to Enhance Health Care

With around 12% of traditional Medicare beneficiaries suffering from heart failure and a quarter grappling with diabetes, the prospect of delivering premade healthy meals to sick senior citizens has gained attention, according to Stat. Although some urge immediate action, others advocate for a congressional directive, highlighting the complexities and challenges of integrating such a program into traditional health care. Medicare officials are currently weighing various options, considering potential benefits and constraints of the program.

Related Videos
RAvin Ratan, MD, MEd, MD Anderson
Amy Shapiro, MD
Ali Khawar
Binod Dhakal, MD
Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council
ISPOR 2024 Recap
Chris Pagnani, MD, PC
Phaedra Corso, PhD, associate vice president for research at Indiana University
Julie Patterson, PharmD, PhD
Michael Morse, MD, Duke Cancer Center
Related Content
CH LogoCenter for Biosimilars Logo